4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-23-010816
Chief Medical Officer sold 16,099 shares at an average $29.87 ($480,843)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Simon Amy Chief Medical Officer | 2023-04-03 | Sale 10b5-1 | −4,445 | $30.31 | $134,728 | 80,962 | D |
| Simon Amy Chief Medical Officer | 2023-04-04 | Sale 10b5-1 | −10,493 | $29.77 | $312,339 | 70,469 | D |
| Simon Amy Chief Medical Officer | 2023-04-04 | Sale 10b5-1 | −1,161 | $29.09 | $33,777 | 69,308 | D |
| Open-market sales · 16,099 sh · avg $29.87 · $480,843 | |||||||
Loading xslF345X04/doc4.xml…